RA CAPITAL MANAGEMENT, LLC Insider Trading $NKTX Nkarta, Inc.
Get free email notifications about insider trading for RA CAPITAL MANAGEMENT, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RA CAPITAL MANAGEMENT, LLC. RA CAPITAL MANAGEMENT, LLC is 10% Owner in LIPID SCIENCES INC/ ($LIPD) and 10% Owner in TG THERAPEUTICS, INC. ($TGTX) and Director in KalVista Pharmaceuticals, Inc. ($CBYL) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Verastem, Inc. ($VSTM) and 10% Owner in Forma Therapeutics Holdings, Inc., ($FMTX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in G1 Therapeutics, Inc. ($GTHX) and 10% Owner in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Wave Life Sciences Ltd. ($WVE) and 10% Owner in Vaxcyte, Inc. ($PCVX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in ARVINAS INC. ($ARVN) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in IMARA Inc. ($IMRA) and Director in Satsuma Pharmaceuticals, Inc. ($STSA) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Solid Biosciences Inc. ($SLDB) and Director in Eidos Therapeutics, Inc. ($EIDX) and 10% Owner in Inhibrx, Inc. ($INBX) and 10% Owner in Orchard Therapeutics plc ($ORTX) and Director in Orchard Therapeutics plc ($ORTX) and Director in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and Director in Nkarta, Inc. ($NKTX) and 10% Owner in Phathom Pharmaceuticals, Inc. ($PHAT) and Director in 89bio, Inc. ($ETNB) and 10% Owner in Pandion Therapeutics, Inc. ($PAND) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and Director in Vor Biopharma Inc. ($VOR) and 10% Owner in Dyne Therapeutics, Inc. ($DYN).
RA CAPITAL MANAGEMENT, LLC in Nkarta, Inc.
Trading Symbol: NKTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RA CAPITAL MANAGEMENT, LLC: Director, 10% Owner
Holdings: 260,819 shares
Latest Transaction: Apr 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RA CAPITAL MANAGEMENT, LLC in Nkarta, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, ACRS, ARVN, DRNA, DYN, EIDX, FMTX, GTHX, IMRA, INBX, INZY, ITOS, ITRM, KALA, KALV, LIPD, NKTX, ORTX, PAND, PHAT, PMVP, RARX, RYTM, STSA, SCPH, SLDB, THOR, TGTX, PCVX, VSTM, VOR, WVE, HOWL
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 32.90 | 307,214 | 10,107,341 | 4,589,999 | 4.3 M to 4.6 M (+7.17 %) |
Apr 05 2021 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | J | 32.90 | 260,819 | 8,580,945 | 260,819 | 0 to 260.8 K |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,405,656 | 0 | 0 | |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | P | 18.00 | 3,333,333 | 59,999,994 | 5,605,129 | 2.3 M to 5.6 M (+146.73 %) |
Jul 16 2020 | NKTX | Nkarta, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Buy | C | 0.00 | 2,271,796 | 0 | 2,271,796 | 0 to 2.3 M |
Page: 1